Brintop L 75mg/20mg Capsule SR
Manufacturer
Rosette Pharmaceuticals
Salt Composition
Levosulpiride (75mg) + Rabeprazole (20mg)
Key Information
Short Description
Brintop L 75mg/20mg Capsule SR is a prescription medicine used to treat gastroesophageal reflux disease (acid reflux), intestinal ulcers, and irritable bowel syndrome.
Dosage Form
Capsule SR
Introduction
Brintop L 75mg/20mg Capsule SR is taken with or without food in a dose and duration as advised by the doctor. The dose you are given will depend on your condition and how you respond to the medicine. You should keep taking this medicine for as long as your doctor recommends. If you stop treatment too early your symptoms may come back and your condition may worsen. Let your healthcare team know about all other medications you are taking as some may affect or be affected by this medicine.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Brintop L 75mg/20mg Capsule SR is to be taken empty stomach.
Safety Information
Side Effects
The most common side effects are nausea stomach pain diarrhea flatulence constipation headache weakness and flu-like symptoms.
Alcohol Warning
It is unsafe to consume alcohol with Brintop L 75mg/20mg Capsule SR.
Breastfeeding Warning
Information regarding the use of Brintop L 75mg/20mg Capsule SR during breastfeeding is not available. Please consult your doctor.
Pregnancy Warning
Brintop L 75mg/20mg Capsule SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
How it works
Brintop L 75mg/20mg Capsule SR is a combination of two medicines: Levosulpiride and Rabeprazole.
Quick Tips
Do not consume alcohol while taking Brintop L 75mg/20mg Capsule SR as it can increase the risk of stomach damage. Long-term use may cause weak or broken bones. Take adequate intake of dietary calcium and vitamin D or their supplements. Do not take Brintop L 75mg/20mg Capsule SR for longer than prescribed.
Related Medicines
Rabonik Plus Capsule SR
Ansuper-Plus Capsule SR
Acera-L Capsule SR
Colosafe-L Capsule SR
Rabemac LS Capsule
Rablet L Capsules
Razo-L Capsule
Veloz L Capsule
Rabicam-LS Capsule SR
Rabrip LS 75mg/20mg Capsule SR
Frequently asked questions
Which is the best time to take Brintop L 75mg/20mg Capsule SR?
Take Brintop L 75mg/20mg Capsule SR exactly as directed by your doctor. It is best taken once daily on an empty stomach.
What are the contraindications associated with the use of Brintop L 75mg/20mg Capsule SR?
Use of Brintop L 75mg/20mg Capsule SR should be avoided in patients with known allergy to any of the components or excipients of this medicine.
Can the use of Brintop L 75mg/20mg Capsule SR cause dizziness?
Yes, some patients may experience dizziness (feeling faint, weak, unsteady, or lightheaded) while taking Brintop L 75mg/20mg Capsule SR. If you feel dizzy, rest in a safe place and resume once you feel better.
Does the use of Brintop L 75mg/20mg Capsule SR lead to increased risk of fractures?
Studies in adults have suggested that treatment with Brintop L 75mg/20mg Capsule SR may be associated with an increased risk of osteoporosis-related fractures in the hip, wrist, or spine. The risk of fracture was elevated in patients taking high doses and those under long-term treatment (a year or longer).
Can I drive while taking Brintop L 75mg/20mg Capsule SR?
Brintop L 75mg/20mg Capsule SR may cause drowsiness, dizziness, or impaired vision. Therefore, do not drive or operate machinery until you are aware of its effect on your body.
What are the instructions for the storage and disposal of Brintop L 75mg/20mg Capsule SR?
Store Brintop L 75mg/20mg Capsule SR in its original packaging, tightly closed. Follow the instructions provided on the product label or packaging. Dispose of unused medicine properly; do not give it to pets, children, or others.
